CELLOXESS
Live / Registered — Registered and renewed (as of 12 Feb 2026)
What this means for you
Registered since 24 Mar 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 Mar 2035: the §8 & §9 renewal).
Record
- Serial number
- 85531283
- Registration number
- 4708577
- Mark type
- Word mark
- Filed
- 01 Feb 2012
- Published for opposition
- 26 Jun 2012
- Registered
- 24 Mar 2015
- Current term from
- 24 Mar 2025
- Next maintenance filing
- §8 & §9 renewal, due by 24 Mar 2035 (grace period to 24 Sept 2035)
Goods and services
- Class 005 — Pharmaceuticals: Dietary and nutritional supplements; Nutraceuticals for the treatment of conditions associated with oxidative stress and DNA damage; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for enhancing fertility; Pharmaceutical preparations for the treatment and prevention of conditions associated with oxidative stress and DNA damage
Owner
Prosecution history
- 12 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Feb 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 Feb 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 08 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 07 Feb 2026 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 04 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 26 Jan 2026 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 26 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Sept 2025 — TEAS SECTION 8 & 9 RECEIVED
- 24 Mar 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 04 May 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 May 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Apr 2021 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 10 Apr 2021 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15